Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

BACKGROUND: Locally advanced or metastatic adenocarcinoma of the pancreas remains - despite the implementation of new chemotherapy protocols - a disease with short overall survival (OS). METHODS: Eighty-three patients were treated with locally advanced or metastatic adenocarcinoma of the pancreas wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogl, Ursula M., Andalibi, Haleh, Klaus, Alexander, Vormittag, Laurenz, Schima, Wolfgang, Heinrich, Bettina, Kafka, Alice, Winkler, Thomas, Öhler, Leopold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325849/
https://www.ncbi.nlm.nih.gov/pubmed/30621630
http://dx.doi.org/10.1186/s12885-018-5240-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325849/
https://www.ncbi.nlm.nih.gov/pubmed/30621630
http://dx.doi.org/10.1186/s12885-018-5240-6

Ejemplares similares